Seroprevalence of Human Herpesvirus 8 and Hepatitis C Virus among Drug Users in Shanghai, China

To elucidate and compare the seroprevalence of human herpesvirus 8 (HHV8) and hepatitis C virus (HCV) among Chinese drug users, a cross-sectional study of 441 participants, was conducted in Shanghai, China, from 2012 through 2013. Seventy-seven (17.5%) participants were found to be positive for HHV8...

Full description

Bibliographic Details
Main Authors: Tiejun Zhang, Ying Liu, Yuyan Zhang, Jun Wang, Veenu Minhas, Charles Wood, Na He
Format: Article
Language:English
Published: MDPI AG 2014-06-01
Series:Viruses
Subjects:
Online Access:http://www.mdpi.com/1999-4915/6/6/2519
_version_ 1818616715950424064
author Tiejun Zhang
Ying Liu
Yuyan Zhang
Jun Wang
Veenu Minhas
Charles Wood
Na He
author_facet Tiejun Zhang
Ying Liu
Yuyan Zhang
Jun Wang
Veenu Minhas
Charles Wood
Na He
author_sort Tiejun Zhang
collection DOAJ
description To elucidate and compare the seroprevalence of human herpesvirus 8 (HHV8) and hepatitis C virus (HCV) among Chinese drug users, a cross-sectional study of 441 participants, was conducted in Shanghai, China, from 2012 through 2013. Seventy-seven (17.5%) participants were found to be positive for HHV8 antibodies, while 271 (61.5%) participants were positive for HCV. No significant association between HHV8 seropositivity and drug use characteristics, sexual behaviors, HCV, or syphilis was observed. In contrast, a statistically significant association between HCV seropositivity and injected drug history (OR, 2.18, 95% CI 1.41–3.37) was detected, whereas no statistically significant association between HCV seropositivity and syphilis infection (OR, 7.56, 95% CI 0.94–60.57) were observed. Pairwise comparisons showed no significant differences between latent and lytic antibodies regarding HCV and HHV8 serostatus. The study demonstrated a moderate but elevated prevalence of HHV8 infection among drug users. The discordance between HHV8 and HCV infections suggests that blood borne transmission of HHV8 might not be the predominant mode of transmission in this population, which is in contrast to HCV.
first_indexed 2024-12-16T16:54:13Z
format Article
id doaj.art-16e16353956e403ba55667451c9747af
institution Directory Open Access Journal
issn 1999-4915
language English
last_indexed 2024-12-16T16:54:13Z
publishDate 2014-06-01
publisher MDPI AG
record_format Article
series Viruses
spelling doaj.art-16e16353956e403ba55667451c9747af2022-12-21T22:23:56ZengMDPI AGViruses1999-49152014-06-01662519253010.3390/v6062519v6062519Seroprevalence of Human Herpesvirus 8 and Hepatitis C Virus among Drug Users in Shanghai, ChinaTiejun Zhang0Ying Liu1Yuyan Zhang2Jun Wang3Veenu Minhas4Charles Wood5Na He6Department of Epidemiology, School of Public Health, Fudan University, and The Key Laboratory of Public Health Safety of Ministry of Education, Shanghai 200032, ChinaDepartment of Epidemiology, School of Public Health, Fudan University, and The Key Laboratory of Public Health Safety of Ministry of Education, Shanghai 200032, ChinaPutuo District Center for Disease Control and Prevention, Shanghai 200032, ChinaDepartment of Epidemiology, School of Public Health, Fudan University, and The Key Laboratory of Public Health Safety of Ministry of Education, Shanghai 200032, ChinaNebraska Center for Virology, School of Biological Sciences, University of Nebraska-Lincoln, Lincoln, NE 68583, USANebraska Center for Virology, School of Biological Sciences, University of Nebraska-Lincoln, Lincoln, NE 68583, USADepartment of Epidemiology, School of Public Health, Fudan University, and The Key Laboratory of Public Health Safety of Ministry of Education, Shanghai 200032, ChinaTo elucidate and compare the seroprevalence of human herpesvirus 8 (HHV8) and hepatitis C virus (HCV) among Chinese drug users, a cross-sectional study of 441 participants, was conducted in Shanghai, China, from 2012 through 2013. Seventy-seven (17.5%) participants were found to be positive for HHV8 antibodies, while 271 (61.5%) participants were positive for HCV. No significant association between HHV8 seropositivity and drug use characteristics, sexual behaviors, HCV, or syphilis was observed. In contrast, a statistically significant association between HCV seropositivity and injected drug history (OR, 2.18, 95% CI 1.41–3.37) was detected, whereas no statistically significant association between HCV seropositivity and syphilis infection (OR, 7.56, 95% CI 0.94–60.57) were observed. Pairwise comparisons showed no significant differences between latent and lytic antibodies regarding HCV and HHV8 serostatus. The study demonstrated a moderate but elevated prevalence of HHV8 infection among drug users. The discordance between HHV8 and HCV infections suggests that blood borne transmission of HHV8 might not be the predominant mode of transmission in this population, which is in contrast to HCV.http://www.mdpi.com/1999-4915/6/6/2519human herpesvirus 8hepatitis C virusdrug userprevalenceChina
spellingShingle Tiejun Zhang
Ying Liu
Yuyan Zhang
Jun Wang
Veenu Minhas
Charles Wood
Na He
Seroprevalence of Human Herpesvirus 8 and Hepatitis C Virus among Drug Users in Shanghai, China
Viruses
human herpesvirus 8
hepatitis C virus
drug user
prevalence
China
title Seroprevalence of Human Herpesvirus 8 and Hepatitis C Virus among Drug Users in Shanghai, China
title_full Seroprevalence of Human Herpesvirus 8 and Hepatitis C Virus among Drug Users in Shanghai, China
title_fullStr Seroprevalence of Human Herpesvirus 8 and Hepatitis C Virus among Drug Users in Shanghai, China
title_full_unstemmed Seroprevalence of Human Herpesvirus 8 and Hepatitis C Virus among Drug Users in Shanghai, China
title_short Seroprevalence of Human Herpesvirus 8 and Hepatitis C Virus among Drug Users in Shanghai, China
title_sort seroprevalence of human herpesvirus 8 and hepatitis c virus among drug users in shanghai china
topic human herpesvirus 8
hepatitis C virus
drug user
prevalence
China
url http://www.mdpi.com/1999-4915/6/6/2519
work_keys_str_mv AT tiejunzhang seroprevalenceofhumanherpesvirus8andhepatitiscvirusamongdrugusersinshanghaichina
AT yingliu seroprevalenceofhumanherpesvirus8andhepatitiscvirusamongdrugusersinshanghaichina
AT yuyanzhang seroprevalenceofhumanherpesvirus8andhepatitiscvirusamongdrugusersinshanghaichina
AT junwang seroprevalenceofhumanherpesvirus8andhepatitiscvirusamongdrugusersinshanghaichina
AT veenuminhas seroprevalenceofhumanherpesvirus8andhepatitiscvirusamongdrugusersinshanghaichina
AT charleswood seroprevalenceofhumanherpesvirus8andhepatitiscvirusamongdrugusersinshanghaichina
AT nahe seroprevalenceofhumanherpesvirus8andhepatitiscvirusamongdrugusersinshanghaichina